TY - JOUR
T1 - Effect of the COVID-19 Pandemic on Surgical Breast Cancer Care in the Netherlands
T2 - A Multicenter Retrospective Cohort Study
AU - Filipe, Mando D.
AU - van Deukeren, Désirée
AU - Kip, Marijn
AU - Doeksen, Annemiek
AU - Pronk, Apollo
AU - Verheijen, Paul M.
AU - Heikens, Joost T.
AU - Witkamp, Arjen J.
AU - Richir, Milan C.
N1 - Publisher Copyright:
© 2020 The Author(s)
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2020/12
Y1 - 2020/12
N2 - BACKGROUND: Coronavirus disease 2019 (COVID-19) has put a strain on regular healthcare worldwide. In the Netherlands, the national screening programs, including for breast cancer, were halted temporarily. This posed a challenge to breast cancer care, because ∼40% of cases are detected through national screening. Therefore, the aim of the present study was to evaluate the effects of the COVID-19 pandemic on the surgical care of patients with breast cancer in the Netherlands.MATERIALS AND METHODS: The present multicenter retrospective cohort study investigated the effects of COVID-19 on patients with breast cancer who had undergone surgery from March 9 to May 17, 2020. The primary endpoints were the number of surgical procedures performed during the study period, tumor characteristics, surgery type, and route of referral. The secondary endpoint was the incidence of postoperative complications during the study period.RESULTS: A total of 217 consecutive patients with breast cancer requiring surgery were included. We found an overall decrease in the number of patients with breast cancer who were undergoing surgery. The most significant decline was seen in surgery for T1-T2 and N0 tumors. A decline in the number of referrals from both the national screening program and general practitioners was observed. The incidence of postoperative complications remained stable during the study period.CONCLUSIONS: The temporary halt of the national screening program for breast cancer resulted in fewer surgical procedures during the study period and a pronounced decrease in surgery of the lower tumor stages.
AB - BACKGROUND: Coronavirus disease 2019 (COVID-19) has put a strain on regular healthcare worldwide. In the Netherlands, the national screening programs, including for breast cancer, were halted temporarily. This posed a challenge to breast cancer care, because ∼40% of cases are detected through national screening. Therefore, the aim of the present study was to evaluate the effects of the COVID-19 pandemic on the surgical care of patients with breast cancer in the Netherlands.MATERIALS AND METHODS: The present multicenter retrospective cohort study investigated the effects of COVID-19 on patients with breast cancer who had undergone surgery from March 9 to May 17, 2020. The primary endpoints were the number of surgical procedures performed during the study period, tumor characteristics, surgery type, and route of referral. The secondary endpoint was the incidence of postoperative complications during the study period.RESULTS: A total of 217 consecutive patients with breast cancer requiring surgery were included. We found an overall decrease in the number of patients with breast cancer who were undergoing surgery. The most significant decline was seen in surgery for T1-T2 and N0 tumors. A decline in the number of referrals from both the national screening program and general practitioners was observed. The incidence of postoperative complications remained stable during the study period.CONCLUSIONS: The temporary halt of the national screening program for breast cancer resulted in fewer surgical procedures during the study period and a pronounced decrease in surgery of the lower tumor stages.
KW - Breast cancer
KW - Complications
KW - Coronavirus disease 2019
KW - Pandemic
KW - Surgery
KW - Breast Neoplasms/pathology
KW - Humans
KW - Middle Aged
KW - SARS-CoV-2
KW - COVID-19/epidemiology
KW - Postoperative Complications/epidemiology
KW - Adult
KW - Female
KW - Aged
KW - Referral and Consultation
KW - Retrospective Studies
KW - Neoplasm Staging
UR - http://www.scopus.com/inward/record.url?scp=85090132771&partnerID=8YFLogxK
U2 - 10.1016/j.clbc.2020.08.002
DO - 10.1016/j.clbc.2020.08.002
M3 - Article
C2 - 32888855
AN - SCOPUS:85090132771
SN - 1526-8209
VL - 20
SP - 454
EP - 461
JO - Clinical breast cancer
JF - Clinical breast cancer
IS - 6
ER -